Comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 vs 4 Hydroxyphenylacetic Aciduria C1848680
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Impaired Androgen Production and 4 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
A disorder where androgen production is impaired in 46,XY individuals. Results in undervirilization and atypical genital development. Treated with hormone replacement and supportive care.
4 Hydroxyphenylacetic Aciduria C1848680
A metabolic disorder where the body cannot properly break down certain amino acids. Typically detected in infancy through screening. Treated with dietary modifications and monitoring.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
0-0
4 Hydroxyphenylacetic Aciduria C1848680
Variable
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
severe
4 Hydroxyphenylacetic Aciduria C1848680
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
Chronic
4 Hydroxyphenylacetic Aciduria C1848680
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
No
4 Hydroxyphenylacetic Aciduria C1848680
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
reproductive
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
endocrine
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-impaired-androgen-production-C5679870 and 4-hydroxyphenylacetic-aciduria-C1848680 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | 4 Hydroxyphenylacetic Aciduria C1848680 | Discriminating power |
|---|---|---|---|
| Genital development | Undervirilization or atypical genitalia may be present in 46,XY infants. | No established genital phenotype is supplied for this metabolite finding. | High |
| Metabolic signs | Primary features are endocrine and developmental rather than amino-acid breakdown. | May reflect impaired handling of certain amino acids, but symptoms are not established here. | Moderate |
| Detection context | Usually considered when atypical genital development is recognized. | Often identified through infant metabolic screening or urine organic-acid testing. | High |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 when
46,XY infant with undervirilization
The description specifically links impaired androgen production to atypical genital development.
High
Need for sex-development evaluation
Endocrine, genetic, and anatomic assessment is appropriate for this reproductive condition.
Moderate
Planning hormone support
Source data mention hormone replacement and supportive care, without specifying a regimen.
Moderate
Choose 4 Hydroxyphenylacetic Aciduria C1848680 when
Abnormal infant metabolic screen
The finding is typically detected in infancy and requires confirmation and interpretation.
Moderate
Urine organic-acid abnormality
4-hydroxyphenylacetic aciduria names a metabolite result, not a proven disease by itself.
High
Dietary management discussion
Source data mention dietary modification and monitoring, but no specific diet is established here.
Low
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | 4 Hydroxyphenylacetic Aciduria C1848680 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY is part of the concept definition. | No characteristic karyotype is established. | A karyotype supports classification of the left condition but does not explain the metabolite finding. |
| Androgen and precursor studies | Results may indicate impaired androgen production; exact cutoffs are not supplied. | No expected androgen pattern is established. | Abnormal endocrine results require specialist interpretation and do not diagnose the right finding. |
| Urine organic acids | No characteristic organic-acid pattern is supplied. | Elevated 4-hydroxyphenylacetic acid may be reported, without a cutoff here. | This is an abnormal result requiring confirmation of cause, not a standalone diagnosis. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
- Outcome
- Described as severe and chronic, but individual outcome is not established.
- Factors
- Degree of undervirilization, endocrine findings, and response to supportive care may matter.
4 Hydroxyphenylacetic Aciduria C1848680
- Outcome
- Described as moderate and chronic, but prognosis is not established from the metabolite name alone.
- Factors
- Underlying cause, confirmation of the abnormality, and monitoring needs may matter.
Time frame: Both are labeled chronic; exact onset and course vary and are not quantified.
Diagnosis must be confirmed before prognostic statements are made.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impact | Atypical genital development and undervirilization are described. Specific developmental complications are not established in the source. Do not infer identical complications from severity labels alone. |
| Metabolic imbalance | Not described as an amino-acid breakdown disorder. May involve impaired metabolism of certain amino acids. The responsible pathway and clinical consequences are not established here. |
| Long-term care needs | May require ongoing hormone and supportive care. May require dietary monitoring if clinically confirmed. Treatment details, doses, and outcomes are not provided. |
Patient education highlights
- HighDifferent meanings
One is a sex-development diagnosis category; the other is a metabolic test abnormality that needs interpretation.
- HighSpecialist review
Results should be reviewed by appropriate endocrine, genetics, or metabolic clinicians.
- MediumAvoid unsupported numbers
Prevalence, laboratory cutoffs, mortality, and medication doses are not established by this comparison.